Previous close | 40.74 |
Open | 40.95 |
Bid | 40.64 x 100 |
Ask | 40.69 x 100 |
Day's range | 40.12 - 41.15 |
52-week range | 21.38 - 48.81 |
Volume | |
Avg. volume | 1,297,758 |
Market cap | 4.401B |
Beta (5Y monthly) | 1.01 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Novavax signs a $1.2 billion licensing deal with France’s Sanofi, guidance from Akamai Technologies misses estimates, and SoundHound stock surges after first-quarter revenue jumps 73%.
The headline numbers for JFrog (FROG) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
JFrog (FROG) delivered earnings and revenue surprises of 14.29% and 1.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?